Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-11-23

Clinical Trial Update: Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examines using acute rosuvastatin to prevent myocardial damage in patients with acute coronary syndrome, including those unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Acute Coronary Syndrome, Angioplasty | Phase 4 | Status: UNKNOWN